Clinical trials
Observational Myelodysplastic Syndromes trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Completed | 4 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire, Amiens | 3 |
| University Hospital, Grenoble | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Hospices Civils de Lyon | 2 |
| Nantes University Hospital | 2 |
| University Hospital, Bordeaux | 2 |
| Celgene | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Groupe Francophone des Myelodysplasies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 25 |
| Leukemia, Myeloid, Acute | 6 |
| Anemia | 2 |
| Leukemia | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Autoimmune Diseases | 1 |
| Disease | 1 |
| Hematologic Diseases | 1 |
| Immune System Diseases | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.